Effect of saikosaponin-d on expression of VEGF and angioprotein-2 in human hepatocellular carcinoma cells

He Shuixiang,Zhu Zhanfang,Lu Xinlan,Zhao Gang,Chen Jinghong,Wang Zhilun,Luo Jinyan
DOI: https://doi.org/10.16016/j.1000-5404.2011.12.004
2011-01-01
Abstract:Objective To observe the effect of saikosaponin-d(SSd) on expression of VEGF and angioptrotein-2(Ang-2) in hepatocellular carcinoma(HCC) SMMC-7721 cells.Methods Human HCC SMMC-7721 cells were induced by LPS and treated with SSd at different concentrations(2.5,5,10,or 20 mg/L) for 48 h.Nimesulide(a COX-2 selective inhibitor) at the concentration of 300 μmol/L served as a positive control.Proliferation of HCC SMMC-7721 cells was measured by MTT assay.Expressions of VEGF and Ang-2 protein as well as VEGF mRNA in HCC SMMC-7721 cells were detected by immunocytochemistry and RT-PCR,respectively.VEGF level in cultured supernatant was measured by ELISA.Results SSd significantly inhibited the growth and proliferation of HCC SMMC-7721 cells.The expression rates of VEGF and Ang-2 were significantly higher in 10 mg/L SSd group than in LPS induction group(80.0% vs 60.0%,86.67% vs 53.33%,P<0.05),while the expression level of VEGF mRNA in HCC SMMC-7721 cells and the VEGF level in cultured supernatant were also significantly higher in 10 mg/L SSd group than in LPS induction group(0.83±0.07 vs 0.09±0.03,655.00±5.56 vs 446.15±5.05 pg/ml,P<0.01),indicating that SSd inhibits the VEGF level in cultured supernatant in a dose-dependent manner.Conclusion SSd exerts its anti-tumor effect through the VEGF and Ang-2 signaling pathways.
What problem does this paper attempt to address?